The Scientist highlighted a new U.S. study showing that a new class of drugs can treat certain bacterial infections without disturbing normal gut bacteria.
UBC microbiologist Kristie Keeney, who wasn’t associated with the work, was quoted in the article.
“It’s a really exciting new way to target pathogens,” said Keeney.